Skip to content

13F-HR filed by NEA Management Company, LLC

NEA Management Company, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:02:01 UTC, with 25 holding rows worth $1,364,146,127.

Accession
0001072613-26-000901
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 25 entries on the cover page, a total value of $1,364,146,127 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,364,146,127 with VALUE read as dollars as filed, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MBX BIOSCIENCES INC COM55287L101Stock3,614,486$211,881,169dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK7,392,301$192,199,826dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock13,222,228$189,342,305dollars as filed
CELCUITY INC15102K100COM1,710,561$136,023,811dollars as filed
SAVARA INC805111101COM24,471,264$126,271,722dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock4,023,219$108,506,217dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM6,692,298$79,839,115dollars as filed
AURINIA PHARMACEUTICALS INC COM05156V102Stock3,969,834$64,291,462dollars as filed
COURSERA INC COM22266M104Stock12,867,769$63,824,135dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,058,570$58,560,092dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,118,621$55,477,825dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,960,169$14,309,234dollars as filed
KORRO BIO INC500946108COMMON STOCK1,297,893$12,862,120dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM3,233,743$9,377,855dollars as filed
NKARTA INC65487U108COMMON STOCK3,568,781$9,350,206dollars as filed
CHAMPIONS ONCOLOGY INC15870P307COM NEW1,713,720$8,568,600dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM4,448,757$8,385,907dollars as filed
INVENTIVA SA46124U107ADS1,462,586$5,396,942dollars as filed
CVRX INC126638105COMMON STOCK1,954,440$3,420,270dollars as filed
MARKER THERAPEUTICS INC57055L206COM NEW1,625,678$1,739,475dollars as filed
LeonaBio Inc04746L203COM464,398$1,657,901dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A478,548$1,304,043dollars as filed
Senti Biosciences, Inc.81726A209COM NEW3,775,615$1,178,747dollars as filed
IMAGENEBIO INC45175G207CMN50,005$229,023dollars as filed
GOSSAMER BIO INC COM38341P102Stock12,500$148,125dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001072613-26-000901this filing2026-11-16
13F-HR/A 0001072613-26-000921 added2026-11-20